デフォルト表紙
市場調査レポート
商品コード
1764086

経口臨床栄養市場-世界の産業規模、シェア、動向、機会、予測、適応症別、流通チャネル別、地域別、競合別、2020~2030年

Oral Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By Distribution Channel, By Region & Competition, 2020-2030F


出版日
ページ情報
英文 180 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

経口臨床栄養市場-世界の産業規模、シェア、動向、機会、予測、適応症別、流通チャネル別、地域別、競合別、2020~2030年
出版日: 2025年06月30日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

経口臨床栄養の世界市場規模は2024年に158億9,000万米ドル、2030年には221億4,000万米ドルに達すると予測され、予測期間中のCAGRは5.68%で成長します。

慢性疾患の増加、患者中心のケアの重視、栄養失調、サルコペニア、悪液質などの病態の有病率の上昇により、市場は力強い成長を遂げています。このような要因が、通常の食事摂取で必要な栄養素を満たすことができない患者に必要不可欠な栄養素を提供する経口臨床栄養製品に対する需要を促進しています。同市場は、栄養補助食品、経腸栄養剤、医療用食品など幅広い製品で構成されており、いずれも臨床現場で患者の回復をサポートし、健康を維持するために配合されています。

市場概要
予測期間 2026~2030年
市場規模:2024年 158億9,000万米ドル
市場規模:2030年 221億4,000万米ドル
CAGR:2025~2030年 5.68%
急成長セグメント 慢性腎臓病
最大市場 北米

市場促進要因

高齢者の増加とそれに伴う栄養不良リスク

主要市場課題

開発途上地域における高コストと償還制限

主要市場動向

臨床栄養製剤の個別化

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の経口臨床栄養市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 適応症別(アルツハイマー病、栄養失調、がん治療、慢性腎臓病、嚥下障害、その他)
    • 流通チャネル別(直接販売と間接販売)
    • 地域別
    • 企業別(2024年)
  • 製品マップ
    • 適応症別
    • 流通チャネル別
    • 地域別

第6章 北米の経口臨床栄養市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米:国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の経口臨床栄養市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋の経口臨床栄養市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の経口臨床栄養市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの経口臨床栄養市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市

第13章 世界の経口臨床栄養市場:SWOT分析

第14章 ポーターのファイブフォース分析

  • 産業内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Abbott Laboratories, Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Nestle SA
  • GlaxoSmithKline plc.
  • Baxter International Inc.
  • Otsuka Holdings, Co. Ltd.
  • Baxter International Inc.
  • Victus, Inc.
  • Danone SA(Nutricia)

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 15208

The Global Oral Clinical Nutrition Market was valued at USD 15.89 billion in 2024 and is projected to reach USD 22.14 billion by 2030, growing at a CAGR of 5.68% during the forecast period. The market is witnessing strong growth due to increasing incidences of chronic diseases, greater emphasis on patient-focused care, and the rising prevalence of conditions like malnutrition, sarcopenia, and cachexia. These factors are driving demand for oral clinical nutrition products, which provide essential nutrients to patients who are unable to meet their dietary needs through regular food intake. The market comprises a broad range of products, such as nutritional supplements, enteral formulas, and medical foods, all formulated to support patient recovery and maintain health in clinical settings.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 15.89 Billion
Market Size 2030USD 22.14 Billion
CAGR 2025-20305.68%
Fastest Growing SegmentChronic Kidney Disease
Largest MarketNorth America

Key Market Drivers

Increasing Geriatric Population and Associated Malnutrition Risks

The global rise in the aging population is a key driver fueling demand for oral clinical nutrition products. As individuals age, they commonly experience reduced appetite, decreased digestive efficiency, and lower nutrient intake-factors that contribute to malnutrition, muscle loss, and weakened immunity. Oral clinical nutrition provides a solution by offering nutrient-dense formulations that are easy to consume and digest. According to the World Health Organization, by 2030, one in six people worldwide will be aged 60 years or older, and this number is expected to double by 2050. With aging comes a higher incidence of chronic diseases and nutritional deficiencies, positioning oral clinical nutrition as an essential component of elderly healthcare.

Key Market Challenges

High Cost and Limited Reimbursement in Developing Regions

The high cost of specialized oral clinical nutrition products remains a significant barrier, particularly in low- and middle-income countries. These products are often not included in government-funded health insurance schemes or essential medicine lists, placing the financial burden on patients and caregivers. Limited reimbursement policies restrict widespread adoption, particularly in underserved areas where healthcare access is already limited. The high production costs associated with disease-specific formulations further elevate retail prices, creating an affordability gap between developed and emerging markets. As a result, despite growing demand, market penetration remains constrained in economically disadvantaged regions.

Key Market Trends

Personalization in Clinical Nutrition Formulations

A growing trend in the oral clinical nutrition market is the development of personalized nutrition solutions. These are tailored to individual patient needs based on variables such as age, medical condition, genetic profile, and metabolic status. Advances in technologies like nutrigenomics and digital health tools are allowing clinicians to assess individual nutrient deficiencies and create targeted formulations that improve treatment outcomes. Personalized nutrition enhances patient compliance and efficacy, especially in complex cases such as cancer care, gastrointestinal recovery, and age-related deficiencies, thus establishing itself as a cornerstone of modern clinical nutrition strategies.

Key Market Players

  • Abbott Laboratories, Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Nestle SA
  • GlaxoSmithKline plc
  • Baxter International Inc.
  • Otsuka Holdings, Co. Ltd.
  • Baxter International Inc.
  • Victus, Inc.
  • Danone SA (Nutricia)

Report Scope

In this report, the Global Oral Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Clinical Nutrition Market, By Indication:

  • Alzheimer's
  • Nutritional Deficiencies
  • Cancer Care
  • Chronic Kidney Disease
  • Dysphagia
  • Others

Oral Clinical Nutrition Market, By Distribution Channel:

  • Direct Sales
  • Indirect Sales

Oral Clinical Nutrition Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oral Clinical Nutrition Market.

Available Customizations

Global Oral Clinical Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Clinical Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Indication (Alzheimer's, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others)
    • 5.2.2. By Distribution Channel (Direct Sales v/s Indirect Sales)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Map
    • 5.3.1. By Indication
    • 5.3.2. By Distribution Channel
    • 5.3.3. By Region

6. North America Oral Clinical Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oral Clinical Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Indication
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Oral Clinical Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Indication
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Oral Clinical Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Indication
        • 6.3.3.2.2. By Distribution Channel

7. Europe Oral Clinical Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Oral Clinical Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. Germany Oral Clinical Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Oral Clinical Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Oral Clinical Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Indication
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Oral Clinical Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Indication
        • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Oral Clinical Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Oral Clinical Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Oral Clinical Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Oral Clinical Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Oral Clinical Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Indication
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Oral Clinical Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Indication
        • 8.3.5.2.2. By Distribution Channel

9. South America Oral Clinical Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Oral Clinical Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Argentina Oral Clinical Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Colombia Oral Clinical Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Oral Clinical Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Oral Clinical Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Saudi Arabia Oral Clinical Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. UAE Oral Clinical Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Pfizer, Inc.
  • 15.3. Bayer AG
  • 15.4. Nestle SA
  • 15.5. GlaxoSmithKline plc.
  • 15.6. Baxter International Inc.
  • 15.7. Otsuka Holdings, Co. Ltd.
  • 15.8. Baxter International Inc.
  • 15.9. Victus, Inc.
  • 15.10. Danone SA(Nutricia)

16. Strategic Recommendations

17. About Us & Disclaimer